Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S303 Treated Red Blood Cells Recovery and Lifespan Study
NCT01711346Phase 2Completed
- Sponsor
- Cerus Corporation
- Start
- Oct 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of amustaline in transfusion-transmitted infection (TTI), sponsored by Cerus Corporation. Started Oct 2012; status: completed.
02
Drugs
amustaline
03
Conditions
transfusion-transmitted infection (TTI)
Beyond the preview
Go deeper on NCT01711346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711346.